Elixir Medical
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
920 N Mccarthy Blvd Ste 100, Milpitas, C...Phone Number
(408) 636-2000Website
www.elixirmedical.comRevenue
$18.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
3
1
1
1
1
About Elixir Medical
Elixir Medical is innovating in vascular medicine by developing disruptive technologies aimed at treating coronary and peripheral artery diseases. The company focuses on transforming vascular interventions to improve patient health and quality of life. Their products include investigational devices and CE mark approved systems, such as the DynamX Coronary Bioadaptor System and DESyne X2 Novolimus Coronary Stent System. Elixir Medical targets healthcare providers and patients affected by cardiovascular diseases, which are a leading cause of death globally.Explore more
Elixir Medical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Elixir Medical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Elixir Medical has new funding data
Website visits: Recent activity has been detected on your website
Elixir Medical, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Elixir Medical had a recent Job posting/layoffs
Earning: See what the market has to say on Elixir Medical recently announced quarterly report
Check if Elixir Medical has recently received funding, and reach out quickly before it becomes old news!
Check out if Elixir Medical is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Elixir Medical
Product Launch: Get notified when Elixir Medical launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Elixir Medical
Compare insights from companies similar to Elixir Medical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Elixir Medical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Elixir Medical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Elixir Medical.
Elixir Medical financials insights
Gather financial insights about Elixir Medical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2005
Series A
$5.3M
Elixir Medical Tech Stack
A closer look at the technologies used by Elixir Medical
Most Recent Scoops
Product Launch
Product Launch, Healthcare Technology
Left Company
Executive Move
Rupa Patel, Executive VP, Finance, has left the organization and now serves as Chief Financial Officer at Alpfa Medical.
Executive Moves, Left Company
New Hire
Executive Move
Elixir Medical has announced that Rupa Patel has joined the organization as Executive Vice President, Finance.
Open Position
New Hire
Executive Move
Executive Moves
Elixir Medical News & Media
Elixir Medical Highlights Results From “Real World” MY-IVL Study Demonstrating Performance of LithiX™ Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Treating Calcified Coronary Lesions
LithiX™ HC-IVL is a novel lithotripsy system designed to facilitate treatment of heart disease exacerbated by the presence of calcium within coronary artery plaquesElixir Medical Announces Significant Late Breaking Clinical Results for DynamX® Bioadaptor Demonstrating Nearly 50% Reduction in Coronary Event Rates vs. Current PCI Standard of Care
Results were presented at the Transcatheter Cardiovascular Therapeutics (TCT) Conference 2025 in San Francisco on October 27, 2025Elixir Medical Announces Key Commercial Milestone With LithiX™ Hertz Contact (HC) Intravascular Lithotripsy System (IVL)
LithiX™ HC-IVL is a novel lithotripsy system designed to facilitate treatment of heart disease exacerbated by the presence of calcium within coronary artery plaquesEuroPCR 2025: Late-Breaking Data Demonstrate Sustained Significantly Lower Event Rates With Elixir Medical’s DynamX Bioadaptor Over Drug-Eluting Stent Through Three Years
Paris, May 21, 2025 (GLOBE NEWSWIRE) -- —Sustained durability of treatment effect with significantly lower TLF rates (2.7% versus 7.2%, p=0.030) with DynamX® compared to DES—
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Elixir Medical
Sign Up For FreeTo access detailed company insights
Elixir Medical is innovating in vascular medicine by developing disruptive technologies aimed at treating coronary and peripheral artery diseases. The company focuses on transforming vascular interventions to improve patient health and quality of life. Their products include investigational devices and CE mark approved systems, such as the DynamX C... Read More
